Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea

NCT02144181 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ulthera, Inc